Skip to content
10-Q

Quarterly Report

DUSA PHARMACEUTICALS INC

0001193125-12-461262

← back to feed
Filed
Nov 9, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 7, 2012 25.03M sh
Shares Diluted Q3 2012 · Sep 30, 2012 25.01M sh
Shares Diluted Q3 2012 · Sep 30, 2012 26.98M sh
Shares Diluted Q3 2012 · Sep 30, 2011 26.44M sh
Shares Diluted Q3 2012 · Sep 30, 2011 26.39M sh
Capex Q3 2012 · Sep 30, 2012 $496.38K
Capex Q3 2012 · Sep 30, 2011 $271.08K
Operating Cash Flow Q3 2012 · Sep 30, 2012 $4.74M
Operating Cash Flow Q3 2012 · Sep 30, 2011 $4.04M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $28.74M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $24.42M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $23.3M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $8.88M
Stockholders Equity Q3 2012 · Sep 30, 2012 $30.41M
Stockholders Equity Q3 2012 · Dec 31, 2011 $28.28M
Current Liabilities Q3 2012 · Sep 30, 2012 $5.69M
Current Liabilities Q3 2012 · Dec 31, 2011 $6.47M
Total Liabilities Q3 2012 · Sep 30, 2012 $11.25M
Total Liabilities Q3 2012 · Dec 31, 2011 $9.74M
Current Assets Q3 2012 · Sep 30, 2012 $39.76M
Current Assets Q3 2012 · Dec 31, 2011 $36.19M
Total Assets Q3 2012 · Sep 30, 2012 $41.66M
Total Assets Q3 2012 · Dec 31, 2011 $38.02M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.06
Eps Diluted Q3 2012 · Sep 30, 2012 $0.02
Eps Diluted Q3 2012 · Sep 30, 2011 $0.13
Eps Diluted Q3 2012 · Sep 30, 2011 $0.15
Eps Basic Q3 2012 · Sep 30, 2012 −$0.06
Eps Basic Q3 2012 · Sep 30, 2012 $0.02
Eps Basic Q3 2012 · Sep 30, 2011 $0.14
Eps Basic Q3 2012 · Sep 30, 2011 $0.16
Sga Expense Q3 2012 · Sep 30, 2012 $2.91M
Sga Expense Q3 2012 · Sep 30, 2012 $8.86M
Sga Expense restated Q3 2012 · Sep 30, 2011 $2.32M
Sga Expense restated Q3 2012 · Sep 30, 2011 $7.32M
Rd Expense Q3 2012 · Sep 30, 2012 $1.7M
Rd Expense Q3 2012 · Sep 30, 2012 $5.96M
Rd Expense Q3 2012 · Sep 30, 2011 $1.31M
Rd Expense Q3 2012 · Sep 30, 2011 $3.74M
Net Income Q3 2012 · Sep 30, 2012 −$1.42M
Net Income Q3 2012 · Sep 30, 2012 $426.34K
Net Income Q3 2012 · Sep 30, 2011 $3.51M
Net Income Q3 2012 · Sep 30, 2011 $4.01M
Operating Income Q3 2012 · Sep 30, 2012 $273.34K
Operating Income Q3 2012 · Sep 30, 2012 $2.72M
Operating Income restated Q3 2012 · Sep 30, 2011 $983.38K
Operating Income restated Q3 2012 · Sep 30, 2011 $3.84M
Gross Profit Q3 2012 · Sep 30, 2012 $8.23M
Gross Profit Q3 2012 · Sep 30, 2012 $29.53M
Gross Profit restated Q3 2012 · Sep 30, 2011 $7.96M
Gross Profit restated Q3 2012 · Sep 30, 2011 $25.51M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $1.51M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $5.36M
Cost Of Revenue restated Q3 2012 · Sep 30, 2011 $1.41M
Cost Of Revenue restated Q3 2012 · Sep 30, 2011 $4.51M